Recherche avancée

Mathieu Lamy occupe le poste de chef de l'exploitation et de vice-président exécutif chez Intact Corporation financière. Il est également premier vice-président des réclamations chez Intact Assurance. Auparavant, il a été directeur de l'information et premier vice-président d'IntAct Labs LLC, vice-président exécutif des opérations d'AXA Life Insurance (Canada) et vice-président exécutif d'AXA Canada, Inc. M. Lamy a obtenu un diplôme de premier cycle de l'Université Laval.

Mr. Mathieu Bonnet is a Chairman at E6 SAS, a Chief Executive Officer & Director at Allego BV, a Chief Executive Officer & Director at Allego NV, a Chief Executive Officer at Allego BV (New) and a President at Spartan Acquisition Corp.
III.
He is on the Board of Directors at Allego BV and Allego NV.
Mr. Bonnet was previously employed as a Chief Executive Officer by Compagnie Nationale du Rhône.
He received his undergraduate degree from Ecole Polytechnique, a graduate degree from École Nationale Supérieure des Mines de Paris and a graduate degree from Université Catholique de Louvain.

Mathieu Bernard Streiff is the founder of American Healthcare Investors LLC, which was founded in 2011.
He held the title of General Counsel & Managing Director at the firm from 2011 to 2019.
Mr. Streiff's current jobs include being a Director at Hawkhill House Ltd.
since 2016, a Director at American Healthcare REIT, Inc. since 2015, a Director at GAHC3 U.K.
Senior Care Holding Ltd., a Director at Coniston Care Centre Ltd.
since 2016, a Director at Orchard St Albans Housing Portfolio Ltd.
since 2015, a Member of the New York State Bar Association, an Executive Vice President at Griffin-American Healthcare REIT Sub-Advisor, LLC since 2012, and an Executive Vice President at Griffin-American Healthcare REIT III Advisor LLC since 2012.
Mr. Streiff's former jobs include being a Director at Trilogy Investors LLC, Executive Vice President & General Counsel at Grubb & Ellis Co. from 2010 to 2011, Executive Vice President & General Counsel at Griffin-American Healthcare REIT II, Inc. from 2012 to 2014, Executive Vice President & General Counsel at Griffin-American Healthcare REIT III, Inc. from 2013 to 2021, an Associate at Latham & Watkins LLP from 2002 to 2006, Secretary, Executive VP & General Counsel at Grubb & Ellis Realty Investors LLC in 2011, and Executive Vice President at Griffin American Healthcare Reit Advisor LLC from 2011 to 2014.
Mr. Streiff's education includes an undergraduate degree from the University of California, Berkeley and a graduate degree from Columbia Law School.

Le Dr Mathieu Simon est président d'Epsilen Bio SRL, président d'Idorsia Ltd, administrateur indépendant d'Asarina Pharma AB, administrateur indépendant de Vaximm AG, président d'Idorsia Pharmaceuticals Ltd, directeur général de Cellectis Therapeutics et administrateur indépendant de LNC Therapeutics SA. Il siège au conseil d'administration de Lysogene SA, Asarina Pharma AB, Affimed NV, Affimed GmbH, Vaximm AG, Messier Maris & Associs SCA et LNC Therapeutics SA. Auparavant, le Dr Simon a occupé les postes de vice-président exécutif, directeur des opérations et directeur médical chez Cellectis SA, de vice-président du marketing et des affaires médicales chez Wyeth Pharmaceuticals LLC, de vice-président du groupe du marketing et des affaires cliniques chez Wyeth-Ayerst International, Inc. et de premier vice-président des opérations mondiales chez Pierre Fabre Mdicament SAS, de directeur général et de chef de la division Pharma mondiale chez Pierre Fabre SA et de président-directeur général chez Takara Bio Europe AB. Il a également siégé au conseil d'administration d'Alliance for Regenerative Medicine, d'Ectycell SASU et de Farmindustria.

Actuellement, Mathieu Vrijsen occupe le poste de président du conseil de surveillance de Casco Phil, de président du conseil de surveillance de Broadview Holding BV et de président du conseil de surveillance de Corbion NV. M. Vrijsen est également membre du conseil d'administration de la Swiss-American Chamber of Commerce, de l'Association européenne des bio-industries, de Desso BV et de Joma Sport BVBA et membre du comité exécutif de l'International Institute for Management Development. Au cours de sa carrière passée, il a occupé le poste de vice-président senior des opérations et de l'ingénierie à l'E.I. du Pont de Nemours & Co.

M. Mathieu O. Floreani est président du conseil d'administration et PDG de Synlab AG, codirecteur de LS Medizin Service GmbH, directeur général du groupe SYNLAB International GmbH et codirecteur de Medizinisches Versorgungszentrum SYNLAB Leverkusen GmbH. Il siège au conseil d'administration de Synlab Diagnsticos Globales SA, ALcontrol Group Ltd, Labco UK Group Ltd et SYNLAB Ltd. M. Floreani était auparavant employé en tant que président, directeur général et directeur par DHL Global Forwarding North America et directeur général de SYNLAB Medizinisches Versorgungszentrum Stuttgart GmbH.

Veronique Lamy has worked as the Director of Human Resources at Eurogerm SA since 1989.

Guy-François Lamy has worked as a Director at Canadian Employers Council and as an Associate at Stikeman Elliott LLP.

Thomas Lamy is the founder of Biosynex SA, founded in 2005, where he holds the title of Director & Vice President.
He was also the founder of Dectra Pharm SAS, founded in 2005, where he held the title of Chief Executive Officer.
Additionally, he is the founder of All.
Diag SAS, founded in 1993, where he held the title of Chairman & Managing Director until 2015.
Dr. Lamy's current job(s) include being the Chief Executive Officer & Director at Biosynex Swiss SA, Chief Executive Officer & Director at Biosynex Premier SA, Chairman at A.J.T.
Financière SAS, and Sales Manager at PBS Orgenics.
Dr. Lamy's former job(s) include being a Director at Theradiag SA in 2022.
Dr. Lamy's education history includes an MBA from École des Hautes Études Commerciales de Paris and a doctorate from Institut National Polytechnique de Lorraine, conferred in 1986.

Tiphanie Lamy is currently the Deputy Managing Director at FLCP & Associés SASU and FLCP & Associes Invest SAS.
She is also a Member-Supervisory Board at Focus Entertainment SA. Previously, she worked as a Director at Tuvalu Media Netherlands BV.

Esdra Lamy currently works at Airline Passenger Experience Association, Inc., as Director.

Emilie Lamy has worked as a Director at Prestige Motor Holdings SA since 2015.

Sebastien Lamy is currently the Managing Director at Keppel Technology & Innovation Pte Ltd.
Prior to this, he worked as the Director-Group Strategy & Development at Keppel Ltd.
and as a Director at M1 Ltd.

Laurence Lamy currently works as a Manager of Corporate Communications at Mersen SA.

Yasemin Lamy joined British International Investment as Deputy CIO in August 2018.
She is responsible for the Catalyst Strategies, a portfolio aimed at transformational, system-level impact and innovation across its target geographies of Africa and South Asia.
Prior to British International Investment, she spent three years building two new portfolios for Omidyar Network: one portfolio to develop empowering digital identity technologies and one portfolio to establish a trendspotting capability.
Previously, she worked across several different roles within capital markets at J.P.
Morgan, starting out in fund-linked derivatives and then as a credit derivatives analyst, before building and leading the impact investment platform for the firm.
Yasemin has published widely and provided expert advice to the OECD, World Economic Forum and others.
She holds a Masters in Financial Mathematics from King’s College, London and a Bachelor in Mathematics and Philosophy from the University of Pennsylvania.

Donzé Aurélia Lamy worked as a Portfolio Manager at Edmond de Rothschild Asset Management (Suisse) SA from 2009 to 2015.

Mr. Arnaud-Guilhem Lamy is a Head of Euro Aggregate Bond Management Strategies at BNP Paribas Asset Management Europe SAS.
He is responsible for euro-aggregate's bond management strategies and is also an expert in socially responsible investment (SRI) for bond management.
Prior to joining BNP Paribas Asset Management in 2010, he was Eurobond Portfolio Manager at Fortis Investments in London (2007-2010), responsible for ABS and covered bonds.
He was a credit analyst at Société Générale Asset Management (2005-2007), after starting his career at Crédit Foncier de France in 2001 as a securitisation specialist.
He graduated in Finance and Economics from the Ecole Nationale de la Statistique et de l'Administration Economique (ENSAE, France, 2001).
He also holds a Master's degree in Applied Mathematics from Dauphine University (Paris, France, 1999).

Guillaume Lamy currently works at Menguy's SA, as Co-Chief Executive Officer, Les Fromageries Occitanes SAS, as Marketing Director, and Sphere Production SA, as Managing Director.

Edouard Lamy is a member of the IT team, specialising in venture deals.
Before joining Apax Partners in August 2003, he worked for three years in the London office of Crescendo Ventures, a global venture capital firm headquartered in California and concentrating on early stage investments in information technology companies.
He previously worked as a business development manager at World Telecom labs, a Brussels-based communications technology company, developing advanced carrier switching equipment solutions.
Prior to that, he spent two years as an investment analyst in New York at SG Capital Partners.
Edouard graduated from Ecole Superieure de Commerce de Paris in 1997.

Caroline Lamy is currently working as the Co-Head of Equity Management at Crédit Mutuel Asset Management SA since 2021.
Previously, she worked as an Analyst at ING Belgium SA (France) in 2001.

Marc Lamy is currently the President of L'Amy, Inc. He was previously the Chairman of Lunettes Grasset & Associés SAS.

Alina Lamy is a Senior Analyst at Morningstar, Inc. (Research).
She completed her undergraduate degree at Illinois Institute of Technology.

Olivier Lamy is currently a Director at Pobi Industrie SA, Pobi Charpentes SA, Perform Habitat SAS, La Barrade SNC, and AST Services SAS.
He previously worked as a Director-Administrative & Finance at A.S.T.
Groupe SA from 2013 to 2016 and as a Senior Manager at Arthur Andersen & Cia from 2001 to 2002.
Mr. Lamy obtained his undergraduate degree from ESCP Europe Campus Paris in 1998 and Burgundy School of Business in 1998.

Marc Lamy has held positions as an Independent Non-Executive Director at Alliances Developpement Immobilier SA and as a Founding Member at Institut Français Des Administrateurs.

Tristan Lamy currently works as the Chief Executive Officer and Director at Alenis SA.

Guillaume Lamy has worked as a Director at Sfar-Midi SA since 2022.

David Lamy currently works at Tradecowall SCRL, as Chief Executive Officer from 2016, Recynam NV, as Managing Director from 2010, and Recyhoc NV, as Director from 2016.

Kenneth S.
Lamy is the founder of The Lamy Group Ltd.
He is currently working as a Director at the National Association of Real Estate Cos.

Jean-Lucien Lamy is currently the Chief Executive Officer at FCI USA LLC.
Prior to this, he worked as a Director at Aliaxis SA.

Ahmad Lamy worked as an Accounts Assistant at Key Resorts Ltd.

Elaine M.
Lamy currently works as a Development Director at Engaging Schools, Inc.

Mr. Philippe Lamy is Co-Founder & Partner at AlphaOne Partners LLP.
He previously worked at Goldman Sachs.

Franck Lamy has worked as an Investment Manager at Demeter Ventures SA since 2014.

Sixtine Lamy has worked as an Associate at Cinven SA since 2019.

Pascal Lamy is currently the Director at Thomson Reuters Founders Share Co., Ltd., the Director at Centre on Regulation in Europe, a Professor at China Europe International Business School, and the President-Emeritus at Jacques Delors Institute.
He was formerly the Director General at the World Trade Organization.

Lucienne Lamy currently works at Cooperative Immobilière de Bretagne, as Director.

Patrick Lamy's career history includes current and former positions as well as education.
Currently, he is the Senior Vice President-Commercial Strategy at Akero Therapeutics, Inc. Previously, he worked at Gilead Sciences, Inc. as the Head-Commercial Strategy & Banking from 2008 to 2018, and at Iovance Biotherapeutics, Inc. as the Vice President-Commercial from 2018 to 2021.
In terms of education, Mr. Lamy holds an MBA from the University of California, Berkeley, and an undergraduate degree from the University of California San Diego.

Mr. Gérard Lamy is a Director-Research at Wendel SA and a Member at The French Society of Financial Analysts.
He received his undergraduate degree from École des Hautes Études Commerciales de Paris.

François Lamy currently works as a Director for the Association Française contre les Myopathies.